How will this new drug change Alzheimer's treatment?

11 months ago
1.92K

The U.S. Food and Drug Administration on Thursday (July 6) granted standard approval to Leqembi, a new Alzheimer's drug which was shown in trials to slow patients' rate of cognitive decline. Gabe Singer explains.

Loading 5 comments...